In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
The global market for Sterile Fill-Finish CMO was estimated to be worth US$ 3465 million in 2023 and is forecast to a readjusted size of US$ 5137.1 million by 2030 with a CAGR of 10.1% during the forecast period 2024-2030
The biologics sterile fill-finish services market is driven by the increasing demand for biopharmaceuticals and the outsourcing of fill-finish operations by pharmaceutical companies. As biologics continue to gain prominence in treating various diseases, there is a growing need for specialized services to ensure the safe and aseptic filling and packaging of these complex molecules. Contract manufacturing organizations (CMOs) offering sterile fill-finish services provide expertise, state-of-the-art facilities, and regulatory compliance, attracting pharmaceutical companies seeking cost-effective and efficient solutions. Additionally, the trend towards personalized medicine and the development of novel biologics further contribute to the market's expansion. However, the market also faces challenges, including the stringent regulatory landscape for biologics and the need to maintain strict quality control to avoid contamination and preserve product efficacy. As competition intensifies, CMOs must invest in advanced technologies and adhere to regulatory guidelines to gain a competitive edge and meet the growing demand for reliable biologics sterile fill-finish services.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sterile Fill-Finish CMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sterile Fill-Finish CMO by region & country, by Type, and by Application.
The Sterile Fill-Finish CMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Fill-Finish CMO.
麻豆原创 Segmentation
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type:
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics
Biosimilar
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sterile Fill-Finish CMO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Sterile Fill-Finish CMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Sterile Fill-Finish CMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Sterile Fill-Finish CMO Product Introduction
1.2 Global Sterile Fill-Finish CMO 麻豆原创 Size Forecast
1.3 Sterile Fill-Finish CMO 麻豆原创 Trends & Drivers
1.3.1 Sterile Fill-Finish CMO Industry Trends
1.3.2 Sterile Fill-Finish CMO 麻豆原创 Drivers & Opportunity
1.3.3 Sterile Fill-Finish CMO 麻豆原创 Challenges
1.3.4 Sterile Fill-Finish CMO 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sterile Fill-Finish CMO Players Revenue Ranking (2023)
2.2 Global Sterile Fill-Finish CMO Revenue by Company (2019-2024)
2.3 Key Companies Sterile Fill-Finish CMO Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sterile Fill-Finish CMO Product Offered
2.5 Key Companies Time to Begin Mass Production of Sterile Fill-Finish CMO
2.6 Sterile Fill-Finish CMO 麻豆原创 Competitive Analysis
2.6.1 Sterile Fill-Finish CMO 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sterile Fill-Finish CMO Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Fill-Finish CMO as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Vials
3.1.2 Prefilled Syringes
3.1.3 Cartridges
3.1.4 Others
3.2 Global Sterile Fill-Finish CMO Sales Value by Type
3.2.1 Global Sterile Fill-Finish CMO Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sterile Fill-Finish CMO Sales Value, by Type (2019-2030)
3.2.3 Global Sterile Fill-Finish CMO Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Vaccines
4.1.2 Biologics
4.1.3 Biosimilar
4.1.4 Other
4.2 Global Sterile Fill-Finish CMO Sales Value by Application
4.2.1 Global Sterile Fill-Finish CMO Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sterile Fill-Finish CMO Sales Value, by Application (2019-2030)
4.2.3 Global Sterile Fill-Finish CMO Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sterile Fill-Finish CMO Sales Value by Region
5.1.1 Global Sterile Fill-Finish CMO Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sterile Fill-Finish CMO Sales Value by Region (2019-2024)
5.1.3 Global Sterile Fill-Finish CMO Sales Value by Region (2025-2030)
5.1.4 Global Sterile Fill-Finish CMO Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sterile Fill-Finish CMO Sales Value, 2019-2030
5.2.2 North America Sterile Fill-Finish CMO Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sterile Fill-Finish CMO Sales Value, 2019-2030
5.3.2 Europe Sterile Fill-Finish CMO Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sterile Fill-Finish CMO Sales Value, 2019-2030
5.4.2 Asia Pacific Sterile Fill-Finish CMO Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sterile Fill-Finish CMO Sales Value, 2019-2030
5.5.2 South America Sterile Fill-Finish CMO Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sterile Fill-Finish CMO Sales Value, 2019-2030
5.6.2 Middle East & Africa Sterile Fill-Finish CMO Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sterile Fill-Finish CMO Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sterile Fill-Finish CMO Sales Value
6.3 United States
6.3.1 United States Sterile Fill-Finish CMO Sales Value, 2019-2030
6.3.2 United States Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sterile Fill-Finish CMO Sales Value, 2019-2030
6.4.2 Europe Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sterile Fill-Finish CMO Sales Value, 2019-2030
6.5.2 China Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sterile Fill-Finish CMO Sales Value, 2019-2030
6.6.2 Japan Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sterile Fill-Finish CMO Sales Value, 2019-2030
6.7.2 South Korea Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sterile Fill-Finish CMO Sales Value, 2019-2030
6.8.2 Southeast Asia Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sterile Fill-Finish CMO Sales Value, 2019-2030
6.9.2 India Sterile Fill-Finish CMO Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sterile Fill-Finish CMO Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Baxter BioPharma Solutions
7.1.1 Baxter BioPharma Solutions Profile
7.1.2 Baxter BioPharma Solutions Main Business
7.1.3 Baxter BioPharma Solutions Sterile Fill-Finish CMO Products, Services and Solutions
7.1.4 Baxter BioPharma Solutions Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.1.5 Baxter BioPharma Solutions Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Profile
7.2.2 Boehringer Ingelheim Main Business
7.2.3 Boehringer Ingelheim Sterile Fill-Finish CMO Products, Services and Solutions
7.2.4 Boehringer Ingelheim Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Vetter Pharma
7.3.1 Vetter Pharma Profile
7.3.2 Vetter Pharma Main Business
7.3.3 Vetter Pharma Sterile Fill-Finish CMO Products, Services and Solutions
7.3.4 Vetter Pharma Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.3.5 Fresenius Kabi Recent Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Profile
7.4.2 Fresenius Kabi Main Business
7.4.3 Fresenius Kabi Sterile Fill-Finish CMO Products, Services and Solutions
7.4.4 Fresenius Kabi Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.4.5 Fresenius Kabi Recent Developments
7.5 Pfizer CentreOne
7.5.1 Pfizer CentreOne Profile
7.5.2 Pfizer CentreOne Main Business
7.5.3 Pfizer CentreOne Sterile Fill-Finish CMO Products, Services and Solutions
7.5.4 Pfizer CentreOne Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer CentreOne Recent Developments
7.6 Aenova
7.6.1 Aenova Profile
7.6.2 Aenova Main Business
7.6.3 Aenova Sterile Fill-Finish CMO Products, Services and Solutions
7.6.4 Aenova Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.6.5 Aenova Recent Developments
7.7 WuXi Biologics
7.7.1 WuXi Biologics Profile
7.7.2 WuXi Biologics Main Business
7.7.3 WuXi Biologics Sterile Fill-Finish CMO Products, Services and Solutions
7.7.4 WuXi Biologics Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.7.5 WuXi Biologics Recent Developments
7.8 Jubilant HollisterStier
7.8.1 Jubilant HollisterStier Profile
7.8.2 Jubilant HollisterStier Main Business
7.8.3 Jubilant HollisterStier Sterile Fill-Finish CMO Products, Services and Solutions
7.8.4 Jubilant HollisterStier Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.8.5 Jubilant HollisterStier Recent Developments
7.9 Bushu Pharmaceuticals
7.9.1 Bushu Pharmaceuticals Profile
7.9.2 Bushu Pharmaceuticals Main Business
7.9.3 Bushu Pharmaceuticals Sterile Fill-Finish CMO Products, Services and Solutions
7.9.4 Bushu Pharmaceuticals Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.9.5 Bushu Pharmaceuticals Recent Developments
7.10 LSNE Contract Manufacturing
7.10.1 LSNE Contract Manufacturing Profile
7.10.2 LSNE Contract Manufacturing Main Business
7.10.3 LSNE Contract Manufacturing Sterile Fill-Finish CMO Products, Services and Solutions
7.10.4 LSNE Contract Manufacturing Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.10.5 LSNE Contract Manufacturing Recent Developments
7.11 Ajinomoto Bio-Pharma Services
7.11.1 Ajinomoto Bio-Pharma Services Profile
7.11.2 Ajinomoto Bio-Pharma Services Main Business
7.11.3 Ajinomoto Bio-Pharma Services Sterile Fill-Finish CMO Products, Services and Solutions
7.11.4 Ajinomoto Bio-Pharma Services Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.11.5 Ajinomoto Bio-Pharma Services Recent Developments
7.12 CMIC CMO
7.12.1 CMIC CMO Profile
7.12.2 CMIC CMO Main Business
7.12.3 CMIC CMO Sterile Fill-Finish CMO Products, Services and Solutions
7.12.4 CMIC CMO Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.12.5 CMIC CMO Recent Developments
7.13 GRAM (Grand River Aseptic Manufacturing)
7.13.1 GRAM (Grand River Aseptic Manufacturing) Profile
7.13.2 GRAM (Grand River Aseptic Manufacturing) Main Business
7.13.3 GRAM (Grand River Aseptic Manufacturing) Sterile Fill-Finish CMO Products, Services and Solutions
7.13.4 GRAM (Grand River Aseptic Manufacturing) Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Developments
7.14 TAIYO Pharma Tech Co.,Ltd.
7.14.1 TAIYO Pharma Tech Co.,Ltd. Profile
7.14.2 TAIYO Pharma Tech Co.,Ltd. Main Business
7.14.3 TAIYO Pharma Tech Co.,Ltd. Sterile Fill-Finish CMO Products, Services and Solutions
7.14.4 TAIYO Pharma Tech Co.,Ltd. Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Developments
7.15 HALIX
7.15.1 HALIX Profile
7.15.2 HALIX Main Business
7.15.3 HALIX Sterile Fill-Finish CMO Products, Services and Solutions
7.15.4 HALIX Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.15.5 HALIX Recent Developments
7.16 Cognate BioServices
7.16.1 Cognate BioServices Profile
7.16.2 Cognate BioServices Main Business
7.16.3 Cognate BioServices Sterile Fill-Finish CMO Products, Services and Solutions
7.16.4 Cognate BioServices Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.16.5 Cognate BioServices Recent Developments
7.17 Afton Scientific
7.17.1 Afton Scientific Profile
7.17.2 Afton Scientific Main Business
7.17.3 Afton Scientific Sterile Fill-Finish CMO Products, Services and Solutions
7.17.4 Afton Scientific Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.17.5 Afton Scientific Recent Developments
7.18 Novasep
7.18.1 Novasep Profile
7.18.2 Novasep Main Business
7.18.3 Novasep Sterile Fill-Finish CMO Products, Services and Solutions
7.18.4 Novasep Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.18.5 Novasep Recent Developments
7.19 Emergent BioSolutions
7.19.1 Emergent BioSolutions Profile
7.19.2 Emergent BioSolutions Main Business
7.19.3 Emergent BioSolutions Sterile Fill-Finish CMO Products, Services and Solutions
7.19.4 Emergent BioSolutions Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.19.5 Emergent BioSolutions Recent Developments
7.20 Seikagaku
7.20.1 Seikagaku Profile
7.20.2 Seikagaku Main Business
7.20.3 Seikagaku Sterile Fill-Finish CMO Products, Services and Solutions
7.20.4 Seikagaku Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.20.5 Seikagaku Recent Developments
7.21 Jiangshu YAOHAI Bio-pharmaceutical
7.21.1 Jiangshu YAOHAI Bio-pharmaceutical Profile
7.21.2 Jiangshu YAOHAI Bio-pharmaceutical Main Business
7.21.3 Jiangshu YAOHAI Bio-pharmaceutical Sterile Fill-Finish CMO Products, Services and Solutions
7.21.4 Jiangshu YAOHAI Bio-pharmaceutical Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Developments
7.22 Akron Biotech
7.22.1 Akron Biotech Profile
7.22.2 Akron Biotech Main Business
7.22.3 Akron Biotech Sterile Fill-Finish CMO Products, Services and Solutions
7.22.4 Akron Biotech Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.22.5 Akron Biotech Recent Developments
7.23 Symbiosis Pharmaceutical Services
7.23.1 Symbiosis Pharmaceutical Services Profile
7.23.2 Symbiosis Pharmaceutical Services Main Business
7.23.3 Symbiosis Pharmaceutical Services Sterile Fill-Finish CMO Products, Services and Solutions
7.23.4 Symbiosis Pharmaceutical Services Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.23.5 Symbiosis Pharmaceutical Services Recent Developments
7.24 Techdow
7.24.1 Techdow Profile
7.24.2 Techdow Main Business
7.24.3 Techdow Sterile Fill-Finish CMO Products, Services and Solutions
7.24.4 Techdow Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.24.5 Techdow Recent Developments
7.25 Vigene Biosciences
7.25.1 Vigene Biosciences Profile
7.25.2 Vigene Biosciences Main Business
7.25.3 Vigene Biosciences Sterile Fill-Finish CMO Products, Services and Solutions
7.25.4 Vigene Biosciences Sterile Fill-Finish CMO Revenue (US$ Million) & (2019-2024)
7.25.5 Vigene Biosciences Recent Developments
8 Industry Chain Analysis
8.1 Sterile Fill-Finish CMO Industrial Chain
8.2 Sterile Fill-Finish CMO Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sterile Fill-Finish CMO Sales Model
8.5.2 Sales Channel
8.5.3 Sterile Fill-Finish CMO Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
听
听
*If Applicable.
